8-K 1 eight-k.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 23, 2003 AMERICAN BIO MEDICA CORPORATION -------------------------------------------------------------------------------- (Exact Name of Registrant as Specified in its Charter)
New York 0-28666 14-1702188 -------------------------------- ------------------------ ------------------------------------ (State or Other Jurisdiction of (Commission File Number) (IRS Employer Identification Number) Incorporation)
122 Smith Road, Kinderhook, NY 12106 ------------------------------------------- --------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (800) 227-1243 ITEM 5. OTHER MATTERS On September 23, 2003, the Registrant's Board of Directors accepted the resignation of Daniel W. Kollin from the Registrant's Board of Directors. Mr. Kollin also served on the Registrant's Audit and Compensation Committees. The Registrant is unaware of any disagreement Mr. Kollin has with the Registrant on any matter relating to the Registrant's operations, policies or practices, nor has Mr. Kollin provided a letter outlining any such disagreements. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMERICAN BIO MEDICA CORPORATION (Registrant) Dated: September 25, 2003 By: /s/ Keith E. Palmer --------------------------- Keith E. Palmer Chief Financial Officer 3